Kidney Transplantation From Hepatitis B Surface Antigen (HBsAg)-Positive Living Donors to HBsAg-Negative Recipients: Benefits and Risks

Clin Infect Dis. 2021 Feb 16;72(4):720-721. doi: 10.1093/cid/ciaa707.

Authors

Wiwat Chancharoenthana¹, Asada Leelahavanichkul²

Affiliations

¹ Nephrology Unit, Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
² Translational Research in Inflammation and Immunology Research Unit, Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

PMID: 32492130
DOI: 10.1093/cid/ciaa707

No abstract available

Publication types

Letter
Comment

MeSH terms

China
Hepatitis B Antibodies
Hepatitis B Core Antigens
Hepatitis B Surface Antigens*
Humans
Kidney Transplantation* / adverse effects
Living Donors
Risk Assessment

Substances

Hepatitis B Antibodies
Hepatitis B Core Antigens
Hepatitis B Surface Antigens